Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer-Reference-Cited by-同舟云学术

Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer

Published:2012-07 Issue:1 Volume:126 Page:47-53
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Fu Siqing,Hennessy Bryan T.,Ng Chaan S.,Ju Zhenlin,Coombes Kevin R.,Wolf Judith K.,Sood Anil K.,Levenback Charles F.,Coleman Robert L.,Kavanagh John J.,Gershenson David M.,Markman Maurie,Dice Kristine,Howard Adrienne,Li Jane,Li Yang,Stemke-Hale Katherine,Dyer Mary,Atkinson Edward,Jackson Ed,Kundra Vikas,Kurzrock Razelle,Bast Robert C.,Mills Gordon B.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference50 articles.

1. PI3K/Akt: getting it right matters;Franke;Oncogene,2008

2. Exploiting the PI3K/AKT pathway for cancer drug discovery;Hennessy;Nat Rev Drug Discov,2005

3. PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients;Kolasa;Cancer Biol Ther,2009

4. Integrated genomic analyses of ovarian carcinoma;Nature,2011

5. Alternate molecular genetic pathways in ovarian carcinomas of common histological types;Willner;Hum Pathol,2007

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Update on Physiopathological Roles of Akt in the ReprodAKTive Mammalian Ovary;Life;2024-06-02

2. Deciphering resistance mechanisms and novel strategies to overcome drug resistance in ovarian cancer: a comprehensive review;Oncology Research;2024

3. Advances in Ovarian Cancer Treatment Beyond PARP Inhibitors;Current Cancer Drug Targets;2023-07

4. Pharmacokinetics of Novel Furoxan/Coumarin Hybrids in Rats Using LC-MS/MS Method and Physiologically Based Pharmacokinetic Model;Molecules;2023-01-13

5. Evaluation of stromal cell infiltration in the tumor microenvironment enable prediction of treatment sensitivity and prognosis in colon cancer;Computational and Structural Biotechnology Journal;2022